Plain-English translation of NCT06546670 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Sickle Cell Disease research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This clinical trial is testing a new medication called to see if it is safe and can help treat sickle cell disease. The study starts by giving healthy volunteers small doses to make sure the medication is safe, then moves on to testing it in people who actually have sickle cell disease. Researchers want to understand how the medication works in your body and whether it can reduce sickle cell symptoms.
Sickle cell disease causes pain, organ damage, and serious complications that are hard to treat with current medications. This medication is being developed to offer patients a new treatment option that might help manage their disease more effectively.
You likely qualify if…
You likely don't qualify if…
If you're a healthy volunteer, you'll receive a single dose of the medication in a controlled setting where doctors will monitor you closely and take blood samples to see how your body processes it. If you have sickle cell disease, you'll likely visit the clinic multiple times to receive the medication (either as a single dose or over a period of time) and have blood tests and other check-ups to measure how well it works and whether it causes any side effects. The study may also include an optional extension phase where patients can continue receiving the medication if it appears to be helping.
AI-generated summary from trial data · Aug 13, 2026 · Not medical advice
United States